| Autor: |
Felipe Ramos Caprini, Guilherme Massote Fontanini, Juarez Roberto de Oliveira Vasconcelos, Fernanda Fernandes Souza, Ajith Kumar Sankarankutty, Marcia Guimarães Villanova, Roberta Chaves Araújo |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Annals of Hepatology, Vol 29, Iss , Pp 101732- (2024) |
| Druh dokumentu: |
article |
| ISSN: |
1665-2681 |
| DOI: |
10.1016/j.aohep.2024.101732 |
| Popis: |
Conflict of interest: No Introduction and Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most important causes of liver disease worldwide, and it is currently the main indication for liver transplantation.This study aims to evaluate (1) clinical-epidemiological profile of patients listed for liver transplant due to MASLD-related cirrhosis and mortality on the waiting list; (2) occurrence of allograft steatosis and new post-transplant comorbidities; (3) survival of patients with and without MASLD in the postoperative period. Patients / Materials and Methods: This retrospective study is based on a review of medical records of patients treated at the Liver Transplant outpatient clinic of the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto - University of São Paulo, from 2005 to 2015. Results and Discussion: Of all patients listed for liver transplant (610), 10% had MASLD-related cirrhosis. Of these, 47.5% were female, with an average age of 56.3 years. These patients had higher MELD values (P = 0.01), higher rates of metabolic syndrome (P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
